The mechanistic target of rapamycin (mTOR) pathway serves as a central link between autophagy and NET regulation: activation of autophagy by rapamycin enhances NET production, whereas mTOR activation, such as that observed in melanoma, suppresses it [80]. The gene discussed is MTOR; the disease is melanoma.